September 17th 2025
Alteogen received a positive CHMP opinion for EYLUXVI in July 2025
September 4th 2025
Dr Ramtohul's research uses electrophysiologic testing to study the retinal ganglion cells
September 3rd 2025
The US Food and Drug Administration (FDA) also granted RMAT designation for MCO-010 in Stargardt disease (SD).
September 1st 2025
Presentation topics will include therapies for age-related macular degeneration, X-linked retinitis pigmentosa and other retinal pathologies
August 28th 2025
Clinical leaders including Susan Schneider, MD; Lejla Vajzovic, MD; and Harvey Uy, MD, will share new clinical findings
AAO 2024: Late-breaking developments in a novel treatment for adolescents with Stargardt disease
A novel oral therapeutic showed promising results in a Phase 2 study involving 13 subjects
Treatment and technology: The future of retina care
How robotics and gene therapies are shaping retina research, now and in the days to come
Alzheimer disease retinopathy and brain-to-eye β-amyloid transport
The research findings highlighted a new therapeutic avenue in ocular and neurodegenerative disease
Study: Oral caffeine intake increases inner electro-retinal activity in young adults
Investigators studied global-flash multifocal electroretinogram responses
What's missing in patient education?
A different approach better serves patients with diabetic retinopathy
EURETINA 2024: David Yorston, FRCS, FRCOphth, says data can unify us
Dr Yorston delivered the Gisbert Richard Lecture at this year's EURETINA Congress
EURETINA 2024: CRISPR-Cas mediated base editing approaches for CRB1 related retinal dystrophy
The e-poster came in 2nd place for the August Deutman award at the EURETINA Congress
EURETINA 2024: New therapeutics for wet AMD address the broader VEGF family
Timothy L Jackson PhD, MB ChB, FRCOphth, speaks about a combination therapy for VEGF-A/C/D inhibition with sozinibercept and ranibizumab
EURETINA 2024: Carl Awh, MD, FASRS, and the American Society of Retina Specialists collaborate at EURETINA
Carl Awh, MD, FASRS, spoke the value of the international community of retina clinicians connecting at global meetings
EU CHMP confirms negative opinion on marketing authorisation application of intravitreal pegcetacoplan from Apellis
The agency confirmed its June 2024 negative opinion after Apellis requested re-examination of the EMA's initial response
EURETINA 2024: Genotype-phenotype correlations in a cohort of patients with genetically determined retinitis pigmentosa
Stefano Mercuri, MD, speaks about his team's August Deutman award-winning research on retinitis pigmentosa and Rho gene mutations
EURETINA 2024: The global VOYAGER study provides real-world, scalable findings
Clare Bailey, MD, shared data from the multi-country study on faricimab for patients with DME and nAMD
EURETINA 2024: Bahram Bodaghi, MD, PHD, FEBO, says the Congress "starts with innovation"
Prof Bodaghi praises the ingenuity at this year's EURETINA Innovation Spotlight (EIS)
EURETINA 2024: Aleksandra Rachitskaya, MD, FASRS, and the Vit-Buckle Society come to Barcelona
Challenging surgical videos from the Vit-Buckle Society symposia and data on the impact of home OCT in management of nAMD
EURETINA 2024: Martin S. Zinkernagel, MD, PhD, on the future of real-world AI use
The general secretary of the European Society of Retina Specialists (EURETINA) says the future of AI is here
EURETINA 2024: Alexandra Miere, MD, PhD, sees oculomics rising to the top
Editorial advisory board member Alexandra Miere, MD, PhD, says oculomics is the next big thing in eye care
EURETINA 2024: Factors predictive of macular oedema development in patients with silicone oil tamponade
Additional previous surgeries and the duration of the SO tamponade had little or no impact
EURETINA 2024: Tyrosine kinase inhibitors and safety data for patients with non proliferative diabetic retinopathy
Veeral Sheth, MD, MBA, FASRS, FACS, discusses outcomes from the Phase 1 HELIOS trial
EURETINA 2024: Boris Stanzel, MD, shares research on fluid monitoring and fixation clouds
New research and EURETINA highlights from the director of the "underdog" eye clinic
EURETINA 2024: Kyoko Ohno-Matsui, MD, PhD, shares a keynote on cutting-edge technologies for pathologic myopia
How retinal imaging can provide clinicians a deeper understanding of myopia
EURETINA 2024: Keynote speaker Yousif Subhi, MD, PhD, on keeping patients in focus
Yousif Subhi, MD, PhD, discusses his Ophthalmologica Lecture, "Things That Matter: An Evidence-Based Approach to AMD and CSC"
EMA announces positive opinion for SB15 (OPUVIZ, Samsung Bioepis and Biogen)
The CHMP will recommend SB15, biosimilar to aflibercept (Eylea), for marketing authorisation by the European Commission
EURETINA 2024: Subretinal drusenoid deposit load and correlation with an increased risk of stroke
Research findings from Moorfields Eye Hospital also indicate SDD and drusen differ in many factors related to stroke risk
EURETINA 2024: Andrea Govetto, MD, PhD, says it takes teamwork to understand macular oedema
We spoke with Andrea Govetto, MD, PhD, winner of the inaugural Ramin Tadayoni Award at EURETINA
EURETINA 2024: Unraveling the genetic spectrum of combined retinal dystrophy and hearing impairment
Researchers in Portugal investigated Usher syndrome, Senior-Loker syndrome and other ciliopathies
EURETINA 2024: Ricardo Leitão Guerra, MD, MSc, FICO, speaks about multimodal imaging
Why having a set process for diagnostic imaging is crucial to patient outcomes
EURETINA 2024: Subretinal gene therapy improves function and structure in patients with Bothnia Dystrophy
Bothnia Dystrophy generally presents during early childhood; patients have night blindness, progressive visual loss, and subsequent legal blindness.
EURETINA 2024: Ocular involvement among patients with COVID-19 infection or vaccination
A case series illuminates neuro-ophthalmologic manifestations, retinal vascular involvement and other pathologies
EURETINA 2024: Cardio-ocular syndrome and retinal microvasculature changes in acute heart failure
The research team used spectral-domain OCT and OCT angiography imaging to study the changes in the retinal microvasculature in patients
EURETINA 2024: Efficacy results and patient preference findings from the Pagoda trial
Dr Margaret A. Chang shares data on the port delivery system with ranibizumab, and her strategy for making the most of conferences